CA2576117C - Dispositif pour l'insertion d'un implant intraoculaire - Google Patents

Dispositif pour l'insertion d'un implant intraoculaire Download PDF

Info

Publication number: CA2576117C
Authority: CA; Canada
Prior art keywords: implant; delivery device; disk; eyeball; tube
Prior art date: 1995-05-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA2576117A

Other languages

English (en)

Other versions

CA2576117A1 (fr

Inventor

Jacob Richter

Gregory Pinchasik

Ira Yaron

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Optonol Ltd

Original Assignee

Optonol Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-14

Filing date

1996-05-13

Publication date

2010-09-07

1995-05-14 Priority claimed from IL11372395A external-priority patent/IL113723A/en

1996-05-13 Application filed by Optonol Ltd filed Critical Optonol Ltd

1996-05-13 Priority to CA2708379A priority Critical patent/CA2708379C/fr

1996-05-13 Priority claimed from CA002220355A external-priority patent/CA2220355C/fr

1996-11-21 Publication of CA2576117A1 publication Critical patent/CA2576117A1/fr

2010-09-07 Application granted granted Critical

2010-09-07 Publication of CA2576117C publication Critical patent/CA2576117C/fr

2016-05-13 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

239000007943 implant Substances 0.000 title claims abstract description 157
230000014759 maintenance of location Effects 0.000 claims abstract description 33
230000007246 mechanism Effects 0.000 claims abstract description 15
230000000149 penetrating effect Effects 0.000 claims abstract description 6
210000005252 bulbus oculi Anatomy 0.000 claims description 51
239000000523 sample Substances 0.000 claims description 6
238000002513 implantation Methods 0.000 abstract description 28
210000001742 aqueous humor Anatomy 0.000 description 29
210000003786 sclera Anatomy 0.000 description 27
210000000795 conjunctiva Anatomy 0.000 description 25
238000000034 method Methods 0.000 description 19
238000003780 insertion Methods 0.000 description 16
230000037431 insertion Effects 0.000 description 16
230000004410 intraocular pressure Effects 0.000 description 14
210000002159 anterior chamber Anatomy 0.000 description 9
239000000463 material Substances 0.000 description 9
208000010412 Glaucoma Diseases 0.000 description 8
206010016717 Fistula Diseases 0.000 description 7
230000003890 fistula Effects 0.000 description 7
239000000126 substance Substances 0.000 description 7
208000002352 blister Diseases 0.000 description 6
210000001508 eye Anatomy 0.000 description 6
238000001914 filtration Methods 0.000 description 6
239000003550 marker Substances 0.000 description 6
229910001220 stainless steel Inorganic materials 0.000 description 6
239000010935 stainless steel Substances 0.000 description 6
238000001356 surgical procedure Methods 0.000 description 6
238000005530 etching Methods 0.000 description 5
230000035515 penetration Effects 0.000 description 5
230000006870 function Effects 0.000 description 4
229920002120 photoresistant polymer Polymers 0.000 description 4
230000008569 process Effects 0.000 description 4
230000001105 regulatory effect Effects 0.000 description 4
230000037390 scarring Effects 0.000 description 4
206010002091 Anaesthesia Diseases 0.000 description 3
230000009471 action Effects 0.000 description 3
230000037005 anaesthesia Effects 0.000 description 3
210000004087 cornea Anatomy 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 3
229910001000 nickel titanium Inorganic materials 0.000 description 3
210000001328 optic nerve Anatomy 0.000 description 3
239000004033 plastic Substances 0.000 description 3
229920003023 plastic Polymers 0.000 description 3
229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
239000004926 polymethyl methacrylate Substances 0.000 description 3
230000001154 acute effect Effects 0.000 description 2
238000004873 anchoring Methods 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
210000004027 cell Anatomy 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000011960 computer-aided design Methods 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000007547 defect Effects 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
230000036407 pain Effects 0.000 description 2
230000002980 postoperative effect Effects 0.000 description 2
210000001525 retina Anatomy 0.000 description 2
239000012781 shape memory material Substances 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
230000000007 visual effect Effects 0.000 description 2
238000003466 welding Methods 0.000 description 2
206010003694 Atrophy Diseases 0.000 description 1
201000004569 Blindness Diseases 0.000 description 1
208000002177 Cataract Diseases 0.000 description 1
206010016654 Fibrosis Diseases 0.000 description 1
208000003098 Ganglion Cysts Diseases 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
229910052689 Holmium Inorganic materials 0.000 description 1
206010051450 Iridocele Diseases 0.000 description 1
229930192392 Mitomycin Natural products 0.000 description 1
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
206010061323 Optic neuropathy Diseases 0.000 description 1
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
206010066902 Surgical failure Diseases 0.000 description 1
208000005400 Synovial Cyst Diseases 0.000 description 1
239000004809 Teflon Substances 0.000 description 1
229920006362 Teflon® Polymers 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
238000001949 anaesthesia Methods 0.000 description 1
230000003444 anaesthetic effect Effects 0.000 description 1
230000037444 atrophy Effects 0.000 description 1
238000005219 brazing Methods 0.000 description 1
210000004240 ciliary body Anatomy 0.000 description 1
238000011109 contamination Methods 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
239000013013 elastic material Substances 0.000 description 1
239000000835 fiber Substances 0.000 description 1
230000004761 fibrosis Effects 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
230000035876 healing Effects 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
KJZYNXUDTRRSPN-UHFFFAOYSA-N holmium atom Chemical compound [Ho] KJZYNXUDTRRSPN-UHFFFAOYSA-N 0.000 description 1
230000000642 iatrogenic effect Effects 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000002690 local anesthesia Methods 0.000 description 1
230000005923 long-lasting effect Effects 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
230000007257 malfunction Effects 0.000 description 1
229960004857 mitomycin Drugs 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000000465 moulding Methods 0.000 description 1
208000020911 optic nerve disease Diseases 0.000 description 1
230000037361 pathway Effects 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
210000001747 pupil Anatomy 0.000 description 1
230000002207 retinal effect Effects 0.000 description 1
231100000241 scar Toxicity 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
229910052715 tantalum Inorganic materials 0.000 description 1
GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
210000001760 tenon capsule Anatomy 0.000 description 1
230000008733 trauma Effects 0.000 description 1

Landscapes

Prostheses (AREA)

CA2576117A 1995-05-14 1996-05-13 Dispositif pour l'insertion d'un implant intraoculaire Expired - Lifetime CA2576117C (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA2708379A CA2708379C (fr)	1995-05-14	1996-05-13	Implant intraoculaire et instrument permettant de le mettre en place

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
IL113723		1995-05-14
IL11372395A IL113723A (en)	1995-05-14	1995-05-14	Intraocular implant
US08/623,238 US5868697A (en)	1995-05-14	1996-03-27	Intraocular implant
US08/623,238		1996-03-27
CA002220355A CA2220355C (fr)	1995-05-14	1996-05-13	Cristallin artificiel, dispositif d'installation et procede d'implantation

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002220355A Division CA2220355C (fr)	1995-05-14	1996-05-13	Cristallin artificiel, dispositif d'installation et procede d'implantation

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2708379A Division CA2708379C (fr)	1995-05-14	1996-05-13	Implant intraoculaire et instrument permettant de le mettre en place

Publications (2)

Publication Number	Publication Date
CA2576117A1 CA2576117A1 (fr)	1996-11-21
CA2576117C true CA2576117C (fr)	2010-09-07

Family

ID=37905009

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2576117A Expired - Lifetime CA2576117C (fr)	1995-05-14	1996-05-13	Dispositif pour l'insertion d'un implant intraoculaire

Country Status (1)

Country	Link
CA (1)	CA2576117C (fr)

1996
- 1996-05-13 CA CA2576117A patent/CA2576117C/fr not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2576117A1 (fr)	1996-11-21

Legal Events

Date	Code	Title	Description
2007-02-09	EEER	Examination request
2016-07-17	MKEX	Expiry	Effective date: 20160513

Publication	Publication Date	Title
US5968058A (en)	1999-10-19	Device for and method of implanting an intraocular implant
EP0957949B1 (fr)	2004-08-04	Cristallin artificiel, dispositif d'installation et procede d'implantation
US5868697A (en)	1999-02-09	Intraocular implant
US6510600B2 (en)	2003-01-28	Method for manufacturing a flow regulating implant
US8313454B2 (en)	2012-11-20	Fluid drainage device, delivery device, and associated methods of use and manufacture
CA2576117C (fr)	2010-09-07	Dispositif pour l'insertion d'un implant intraoculaire
CA2220355C (fr)	2007-04-10	Cristallin artificiel, dispositif d'installation et procede d'implantation